Möchten Sie immer auf dem neuesten Stand bleiben?

CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner’s Program Size Positions it to Become a Top Five...

Halo Pharma is expanding its manufacturing capabilities with the addition of a Gerteis Macro-Pactor at its Whippany, NJ, facility.

CHASKA, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

Ottawa, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The global biologics CDMO market size is expected to hit nearly USD 92.37 billion by 2034, increasing from USD 29.27 billion in 2026, growing at a strong...

Dublin, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients CDMO Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" report has been added to ...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

New advisory board brings further world-class expertise in oncology, neurology, geographic market expansion, and AI enabled clinical trial delivery to support biotech innovators LETCHWORTH GARDEN...

Dipharma publishes a peer-reviewed study introducing a novel 15N NMR–based NAP strategy to detect nitrosamines and strengthen API safety and compliance.